Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Understanding mechanisms of resistance to FLT3 inhibitors in adult FLT3-mutated acute myeloid leukemia to guide treatment strategy
Martina Ruglioni, Stefania Crucitta, Giovanna Irene Luculli, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 201, pp. 104424-104424
Open Access | Times Cited: 10

Showing 10 citing articles:

Molecular principles underlying aggressive cancers
Ruth Nussinov, Bengi Ruken Yavuz, Hyunbum Jang
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Mechanistic Insights into the Anticancer Potential of Methoxyflavones Analogs: A Review
Mohammad Aidiel, Maisarah Abdul Mutalib, Rajesh Ramasamy, et al.
Molecules (2025) Vol. 30, Iss. 2, pp. 346-346
Open Access
Discovery of novel and highly potent small molecule inhibitors targeting FLT3-ITD for the treatment of acute myeloid leukemia using structure-based virtual screening and biological evaluation
Kun Shi, Ye Hong, Huajing Liu, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Advances in the pathogenesis of FLT3-mutated acute myeloid leukemia and targeted treatments
Serena Travaglini, Carmelo Gurnari, Tiziana Ottone, et al.
Current Opinion in Oncology (2024)
Closed Access | Times Cited: 3
Molecular Features and Treatment Paradigms of Acute Myeloid Leukemia
Mihir Shukla, Maher Abdul‐Hay, Jun‐Hui Choi
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1768-1768
Open Access | Times Cited: 2
Enhancing Therapeutic Efficacy of FLT3 Inhibitors with Combination Therapy for Treatment of Acute Myeloid Leukemia
Malia E. Leifheit, Gunnar Johnson, Timothy M. Kuzel, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9448-9448
Open Access | Times Cited: 2
Novel Mechanistic Insights into the Anticancer Potential of Methoxyflavones Analogs: A Review
Mohammad Aidiel, Maisarah Abdul Mutalib, Rajesh Ramasamy, et al.
(2024)
Open Access | Times Cited: 1
Gene regulatory network and signalling pathway rewiring: How blood cancer cells shift their shapes to evade drug treatment
Constanze Bonifer, Peter N. Cockerill
Oncotarget (2024) Vol. 15, Iss. 1, pp. 714-716
Open Access
Efficacy and safety of second‑generation FLT3 inhibitors in acute myeloid leukemia: A systematic review and meta‑analysis of randomized controlled trials
Wei‐Ting Lin, Chien‐Ming Chao, Cheng-Yao Lin, et al.
Molecular and Clinical Oncology (2024) Vol. 21, Iss. 6
Open Access
Targeting FMS-like tyrosine kinase 3 (FLT3) in acute myeloid leukemia: Novel molecular approaches and therapeutic challenges
Jan Rataj, Lukáš Górecki, Darina Muthná, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 182, pp. 117788-117788
Open Access
Page 1

Scroll to top